Last reviewed · How we verify
Aldosteronism
Approved treatments
- Spironolacton · ACS Biomarker
- Aldactone · Generic (originally Searle/Pfizer)
Potassium-sparing diuretic and mineralocorticoid receptor antagonist that blocks aldosterone, reducing fluid retention and lowering blood pressure. - spirolactone · Second Xiangya Hospital of Central South University
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Aldosteronism patent landscape — cliff calendar, originator estates, attackable patents
- Aldosteronism treatment landscape brief
- Aldosteronism treatment updates RSS
Frequently asked questions about Aldosteronism
What drugs treat Aldosteronism?
Tracked treatments include Spironolacton, Aldactone, spirolactone.
What is the treatment for Aldosteronism?
Standard treatment for Aldosteronism includes Spironolacton, Aldactone, spirolactone. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Aldosteronism patent cliff · Aldosteronism CI report
- Treatment: Spironolacton · ACS Biomarker
- Treatment: Aldactone · Generic (originally Searle/Pfizer)
- Treatment: spirolactone · Second Xiangya Hospital of Central South University
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing